PhD Studentships at Whitelab Genomics

Closing Date and Start Date: November 2020

The recent FDA approvals of gene therapies for rare eye and motor neurons genetic diseases are just an example of how adeno-associated virus (AAV) vectors are dramatically changing patients’ lives. Rare metabolic conditions are another category of diseases that attracted the utmost attention. Early reports of liver gene transfer in preclinical models indicated long-term stability of gene transfer. While in haemophilia B patients, 10-year gene transfer stability was reported, these results were only partially confirmed in haemophilia A where reduced efficacy was reported at long-term. These results suggest that disease-specific conditions may affect the AAV genome stability in hepatocytes and are associated with reduced persistence. Random integration is another consequence of long-term persistence of AAV vector genomes and may represents an underestimated risk.

This project aims at the consolidation of the knowledge existing on the molecular signatures of long-term persistence of AAV vectors in the host nuclei in healthy and diseased liver. Specifically, persistence, genome integrity of the AAV vector and random integration will be assessed using state-of-the-art and in-house developed NGS assays. The generated experimental results will be integrated into a biological knowledge graph and artificial intelligence algorithms will be harnessed to identify and overcome the limitations of the technical approaches used in the past for this purpose, and to improve AAV vector selection/generation. Genetic animal models of liver disease, available at the host laboratory will be used to evaluate how transgene expression stability is affected by hepatocyte metabolism impairment. The knowledge accumulated during this project will be used to create next-generation transgene expression cassette for AAV gene therapy approaches with improved persistence and reduced insertional risk. Importantly, this new generation of vectors, will represent a unique tool to address both genetic and diet-induced metabolic diseases associated with liver degeneration, a crucial medical need in developing countries.

Contacts: Prospective candidates are strongly encouraged to email Dr. Julien Cottineau jcottineau@whitelabgx.com, Dr. Kevin Cheeseman kcheeseman@whitelabgx.com and Dr. Giuseppe Ronzitti giuseppe.ronzitti@inserm.fr.

Read the call for PhD Studentship

À lire aussi

diiP Projects Day: December 6th, 2023

diiP Projects Day: December 6th, 2023

Join us for the diiP Projects Day, an in-person event that will highlight past and upcoming projects, offer opportunities for discussions and networking, and host Prof. Joseph Sifakis (Turing Award winner, 2007) for the last Distinguished Lecture of 2023....

diiP call for proposals 2024

diiP call for proposals 2024

The Data Intelligence of Paris funds two types of projects: Strategic projects and Master's internships. Those projects start in January. The deadline to apply for the 2024 call for projects is October 22nd, 2023, at 11:59 PM (CET). ...